Invest in

Fighting Fat

37.4%
12.5%
0.3%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
37.4%
12.5%
0.3%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
38.1% Weight Loss Drugs --
38.1% Arena Pharmaceuticals Inc. ARNA --
32.8% Diabetes Care 12.6%
10.0% Merck & Company Inc. (new) MRK 18.2%
9.8% Sanofi SNY 26.3%
8.5% Novo Nordisk A/S NVO 14.7%
1.8% Astrazeneca Plc ADR AZN 26.9%
1.4% Alkermes plc ALKS 37.8%
1.3% Integer Holdings Corporation ITGR --
29.2% Weight Management 93.2%
14.6% NutriSystem Inc NTRI 118.5%
6.0% Weight Watchers International Inc WTW 132.2%
4.9% MEDIFAST INC MED 32.4%
2.4% Nu Skin Enterprises Inc. (A) NUS 32.7%
0.6% USANA Health Sciences Inc. USNA 10.7%
0.4% Vitamin Shoppe Inc VSI 67.0%
0.3% GNC Holdings Inc. Class A GNC 69.4%

Quotes delayed 15 mins. Currently Jun 22, 2017 9:53:10 PM. Fields are marked with -- when data is unavailable.